Abstract CN14
Background
This study is part of the implementation of m-Health in outpatient Clinical Pharmacy at Hospital of the Principality of Andorra, with the aim of knowing the qualification of the Abeona Health App by the patient when using it for three months. The main objectives are: 1. Determine the general rating of the App according to the patient. 2 and 3. Know if the patient would continue using the App for one year and if they would recommend the App.
Methods
Cross-sectional study in onco-haematological patients under treatment with OAAs. 1. Inclusion criteria: all adult patients treated with OAAs seen from November 2022 to May 2023 (6 months of study). 2. Tool measure: the validated spanish translation of uMars survey was chosen to meet the research objectives. 3. Data collected from the patients: age, sex, type of tumour and type of OAAs. 4. Data collected from the surveys: the uMARS questions that were used to evaluate the Abeona Health App were: 2.4, 5, 6, 7, 8, 9, 10, 11, 12, 17, 18, and 20. 5. Statistical analysis: descriptive, performed with the Jamovi statistical package. 6. Ethical aspects: before providing the surveys, the patients were informed that their data would be treated anonymously, and they gave their signed informed consent to participate.
Results
64 patients were visited. 44 participated in the study (4 of them through their children for not knowing how to use an App). 41 were women (64%) and 23 men (36%) with a mean age of 63 years. The most frequent tumor in women was the breast with OAAs Palbocilic and in men the Colon with Capecitabine. The general quality of the App according to the patient's response in the uMars survey was: 7.7% of the patients scored 3, 50% scored 4 and 42.3% scored 5. When referring to the use of the App for a year, 19.2% of the patients responded from 3 to 10 times, 46.2% from 10 to 50 times, and 34.6% more than 50 times. In relation to whether patients would recommend the App, 30.8% of the patients answered that they would recommend it to many people and 69.2% that they would recommend it to everyone.
Conclusions
1. The Abeona Health App was rated with a score of more than 4 for 92.3% of patients. 2. The 80.8% of patients would continue using it for a year. 3. The 100% of patients would recommend it to people who could benefit from it.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
CN75 - Validation of a symptom diary for outpatients with cancer receiving intravenous chemotherapy and/or targeted therapy
Presenter: José Koldenhof
Session: Poster session 25
Resources:
Abstract
CN86 - Advanced breast cancer care for nurses (ABC4Nurses): A mixed-methods evaluation of an online educational programme
Presenter: Sarah Sheehan
Session: Poster session 25
Resources:
Abstract
CN87 - An accreditation tool towards safe quality cancer nursing care
Presenter: Fernanda Conceição
Session: Poster session 25
Resources:
Abstract
CN88 - Handling cancer drugs: Inventory of the state of knowledge and educational opportunities in Sweden
Presenter: Anki Delin Eriksson
Session: Poster session 25
Resources:
Abstract
CN89 - In cancer care nursing, does the use of surface wipe sampling for hazardous drugs lead to a safer occupational environment, in an outpatient and inpatient oncology/haematology setting? An evidence translation proposal
Presenter: Audrey O'Halloran
Session: Poster session 25
Resources:
Abstract
CN90 - Managing the increasing capacity pressures in a nurse-led rural, satellite oncology unit in the era of immunotherapy
Presenter: SANDRA MURPHY
Session: Poster session 25
Resources:
Abstract
CN91 - Mentors' roles and responsibilities expected by nursing students in clinical training at the institute of oncology Ljubljana, Slovenia
Presenter: Miladinka Matković
Session: Poster session 25
Resources:
Abstract
CN92 - Nursing students’ attitude towards care of dying: A cross-sectional study in Italy
Presenter: Mayra Veronese
Session: Poster session 25
Resources:
Abstract
CN93 - Strategic patient collaboration, cancer theme Karolinska comprehensive cancer center (CCC)
Presenter: Ann-Britt Johansson
Session: Poster session 25
Resources:
Abstract
CN94 - The effect of a compassion fatigue resiliency program on oncology-hematology nurses' professional quality of life, stress levels and patients' care satisfaction: Nurse, patient and nurse manager’s perspectives
Presenter: Tugba Pehlivan Sarıbudak
Session: Poster session 25
Resources:
Abstract